Literature DB >> 13575682

An alternative mechanism for the properdin system.

R A NELSON.   

Abstract

Evidence is presented that phenomena ascribed to the properdin system may be explained in terms of classical antibody (Ab) in combination with three of the components of complement (C'), i.e., C'(1), C'(4), and C'(2) respectively. The results suggest that the complex of properdin (P) with zymosan (Z) represents a mixture of Z.Ab, Z.Ab.C'(1, 4), Z.Ab-C'(1, 4, 2), and Z.Ab.C'(1, 4, 2) in a decayed state. The purported preferential reactivity of Z with the third component of C' (C'(3)) is not supported by the present experiments in which Z was reacted with C' in both guinea pig and human sera. Approximately the same number of reactive units of C'(1, 4) and of C'(3) were inactivated by Z, as well as by D. pneumoniae and a washed specific precipitate of bovine albumin-anti-albumin. The latter evidence that small amounts of antigen-antibody complex fix significant amounts of C'(3) stands in contrast with the classical concept that C'(3) is not fixed in ordinary complement fixation reaction. The observed reactivity of C'(3) is explained on the basis of the present use of essentially undiluted serum as a source of C'(3) and of 37 degrees as the temperature for fixation. Ancillary data indicate that purified properdin contains Ab. In the presence of a chelating agent and at 0 degrees properdin agglutinated Z granules. Measurements of nitrogen (N) uptake by Z suggest that 0.25 microg. N were contributed by solutions stated to contain 1 unit of properdin. The broad spectrum of reactivity or cross-reactivity of the Ab in normal serum is likely due to the wide distribution in nature of closely related polysaccharides. Further immunochemical studies are necessary to establish definitively the origin and mode of action in "natural resistance" of antibodies reactive with these polysaccharides.

Entities:  

Keywords:  PROPERDIN

Mesh:

Substances:

Year:  1958        PMID: 13575682      PMCID: PMC2136897          DOI: 10.1084/jem.108.4.515

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  C F HINZ; W S JORDAN; L PILLEMER
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

2.  Studies on the mechanism of hemolysis by antibody and complement.

Authors:  M M MAYER
Journal:  Prog Allergy       Date:  1958

3.  The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.

Authors:  P A HERBUT; W H KRAEMER
Journal:  Cancer Res       Date:  1956-12       Impact factor: 12.701

4.  Kinetic studies on immune hemolysis. VI. Resolution of the C'y reaction step into two successive processes involving C'2 and C'3.

Authors:  L LEVINE; M M MAYER; H J RAPP
Journal:  J Immunol       Date:  1954-12       Impact factor: 5.422

5.  Kinetic studies on immune hemolysis. VII. Decay of EAC'1, 4, 2, fixation of C'3, and other factors influencing the hemolytic action of complement.

Authors:  M M MAYER; L LEVINE; H J RAPP; A A MARUCCI
Journal:  J Immunol       Date:  1954-12       Impact factor: 5.422

6.  Kinetic studies on immune hemolysis. V. Formation of the complex EAC'x and its reaction with C'y.

Authors:  L LEVINE; M M MAYER
Journal:  J Immunol       Date:  1954-12       Impact factor: 5.422

7.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

8.  NEUTRALIZATION OF BACTERIOPHAGE BY THE PROPERDIN SYSTEM.

Authors:  H Van Vunakis; J L Barlow; L Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1956-07       Impact factor: 11.205

9.  Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.

Authors:  M LANDY; L PILLEMER
Journal:  J Exp Med       Date:  1956-06-01       Impact factor: 14.307

10.  Cross-reactions of antityphoid and antiparatyphoid B horse sera with various polysaccharides.

Authors:  F CORDOBA; M HEIDELBERGER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

View more
  29 in total

1.  Development of bactericidal properties against gram-negative organisms in the serum of young animals.

Authors:  J STERZL; J KOSTKA; A LANC
Journal:  Folia Microbiol (Praha)       Date:  1962-05       Impact factor: 2.099

2.  The properdin content of maternal and infant blood.

Authors:  L L GRIFFITHS; C K RAO; P N SWIFT
Journal:  Arch Dis Child       Date:  1962-12       Impact factor: 3.791

3.  Serum and tissue inhibitors of virus.

Authors:  H S GINSBERG
Journal:  Bacteriol Rev       Date:  1960-03

4.  Antibacterial systems of serum in relation to nonspecific immunity to infection.

Authors:  D ROWLEY
Journal:  Bacteriol Rev       Date:  1960-03

5.  [Experimental contribution to the problem of inactivation of bacteriophages by the properdin system].

Authors:  K H HUSMANN
Journal:  Z Hyg Infektionskr       Date:  1959

6.  Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C' hemolysis by cold agglutinins.

Authors:  R S Evans; E Turner; M Bingham
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

7.  On the mechanism of immune-adherence. II. Analogy to mixed aggregation of sensitized antigens in the presence of complement; immune-adherence with animal platelets.

Authors:  R A NELSON; D S NELSON
Journal:  Yale J Biol Med       Date:  1959-02

Review 8.  Properdin: New roles in pattern recognition and target clearance.

Authors:  Claudia Kemper; Dennis E Hourcade
Journal:  Mol Immunol       Date:  2008-08-08       Impact factor: 4.407

9.  THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. IV. NORMAL ANTIBODY AND EARLY IMMUNE ANTIBODY OF RABBIT ORIGIN: A COMPARISON OF BIOLOGICAL AND PHYSICOCHEMICAL PROPERTIES.

Authors:  S E SVEHAG
Journal:  J Exp Med       Date:  1964-04-01       Impact factor: 14.307

10.  Enhancement of resistance to infectious diseases by oral administration of brewer's yeast.

Authors:  Y Sinai; A Kaplun; Y Hai; B Halperin
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.